An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis

ClinicalTrials.gov ID: NCT06836232

Public ClinicalTrials.gov record NCT06836232. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 6, 2026, 8:43 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a, Open-Label Pilot Study to Evaluate the Safety/Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of VTX2735 in Participants With Recurrent Pericarditis

Study identification

NCT ID: NCT06836232
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Zomagen Biosciences Ltd.; Industry
Enrollment: 50 participants

Conditions and interventions

Conditions

Recurrent Pericarditis

Interventions

VTX2735 Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 75 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jan 27, 2025
Primary completion: Sep 30, 2027
Completion: Sep 30, 2027
Last update posted: May 4, 2026

2025 – 2027

United States locations

U.S. sites: 16
U.S. states: 13
U.S. cities: 15

Facility	City	State	ZIP	Site status
Local Site #840012	Tucson	Arizona	85718	Withdrawn
Local Site #840014	Orange	California	92868	Recruiting
Local Site #840016	Saint Augustine	Florida	32086	Recruiting
Local Site #840008	Chicago	Illinois	60611	Recruiting
Local Site #840002	Park Ridge	Illinois	60068	Withdrawn
Local Site #840011	Owensboro	Kentucky	42303	Withdrawn
Local Site #840010	Boston	Massachusetts	02114	Recruiting
Local Site #840005	Rochester	Minnesota	55905	Recruiting
Local Site #840020	New York	New York	10032	Recruiting
Local Site #840017	Cleveland	Ohio	44195	Recruiting
Local Site #840019	Houston	Texas	77030	Recruiting
Local Site #840001	Houston	Texas	77034	Recruiting
Local Site #840013	Salt Lake City	Utah	84132	Recruiting
Local Site #840018	Charlottesville	Virginia	22908	Recruiting
Local Site #840004	Richmond	Virginia	23219	Recruiting
Local Site #840021	Seattle	Washington	98105	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06836232, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 4, 2026 · Synced May 6, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06836232 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →